Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies | Aplastic Anemia and MDS International Foundation

Clinical Trial: NCT01839916

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov:
Purpose: 

This pilot phase II trial studies how well giving donor T cells after donor stem cell transplant works in treating patients with hematologic malignancies. In a donor stem cell transplant, the donated stem cells may replace the patient's immune cells and help destroy any remaining cancer cells (graft-versus-tumor effect). Giving an infusion of the donor's T cells (donor lymphocyte infusion) after the transplant may help increase this effect.

Status: 
Recruiting
Study Date: 
Mon, 04/01/2013 to Thu, 12/01/2016
Bone Marrow Disease(s): 
myelodysplastic syndromes (MDS)
Intervention: 
Biological: therapeutic allogeneic lymphocytes Given IV Other Name: ALLOLYMPH Other: laboratory biomarker analysis Correlative studies